Study Finds More MMR/MMRV Death Reports Than Deaths from Measles
A new study has found a significant number of deaths among infants and toddlers within days of receiving MMR/MMRV combination vaccines, particularly after the routine first-dose at 12 to 15 months, with reported deaths exceeding documented measles fatalities in the United States.1 The preprint, which examined Vaccine Adverse Event Reporting System (VAERS) death reports, identified […]
What’s Really Going On in South Carolina’s Measles Outbreak?
As of early February 2026, South Carolina remains the center of the largest measles outbreak in the U.S. in over 30 years. With 920 confirmed cases and over 90% reportedly occurring in “unvaccinated” individuals, headlines suggest a crisis of vaccine refusal. But beneath the headlines lies a more complex picture—one shaped by data classification, eligibility […]
FDA Refuses to Review Moderna’s mRNA Influenza Shot License Application
The U.S. Food and Drug Administration (FDA) has declined to accept for review Moderna’s Biologics License Application (BLA) for its mRNA-based seasonal influenza shot, citing concerns about the completeness of the submission. The decision highlights the agency’s commitment to maintaining clear evidentiary standards for approving the licensing of new vaccines.1 On Feb. 3, 2026, the […]
American Medical Association Launches Its Own Vaccine Review Process
The American Medical Association (AMA), a medical trade advocacy association, is partnering with a vaccine research group to launch what it describes as an independent, “evidence-based review process” for respiratory vaccines for the next flu season—a role traditionally carried out by the U.S. Centers for Disease Control and Prevention (CDC).1 2 According to a prepared […]
AAP Issues Its Own Recommended Childhood Vaccine Schedule
The American Academy of Pediatrics (AAP) has released its own recommended childhood vaccine guidance, breaking with updated recommendations issued earlier this month by the U.S. Centers for Disease Control and Prevention (CDC).1 On Jan. 6, 2026, the CDC formally updated the U.S. childhood vaccination schedule, introducing changes as to how vaccines are categorized and recommended. […]
FDA Requires Vaccine Makers to Include Febrile Seizure Warning on Flu Shot Labels
The U.S. Food and Drug Administration (FDA) notified six influenza vaccine manufacturers on Jan. 9, 2026 that they must add a warning about the risk of febrile (fever) seizures to their product information labels, citing newly identified postmarketing safety data. The notices, issued under the FDA’s statutory authority to mandate safety labeling changes, were sent […]